Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce
暂无分享,去创建一个
A. Iagnocco | L. Gossec | J. Smolen | D. Aletaha | A. Zabotti | D. McGonagle | J. Emmel | G. de Marco | X. Baraliakos | Paulo Gisondi
[1] D. Aletaha. The undifferentiated arthritis dilemma: the story continues , 2022, Nature Reviews Rheumatology.
[2] D. Aletaha,et al. Intercepting psoriatic arthritis in patients with psoriasis: buy one get one free? , 2021, Annals of the Rheumatic Diseases.
[3] A. Iagnocco,et al. Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis , 2021, Rheumatology and Therapy.
[4] E. Soriano,et al. Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis , 2021, Annals of the Rheumatic Diseases.
[5] P. Gisondi,et al. Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis , 2021, Annals of the Rheumatic Diseases.
[6] F. V. D. van den Hoogen,et al. Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review , 2021, Arthritis Research & Therapy.
[7] J. Walsh,et al. Psoriasis Characteristics for the Early Detection of Psoriatic Arthritis , 2021, The Journal of Rheumatology.
[8] A. Julià,et al. Synovial Immunohistological Biomarkers of the Classification of Undifferentiated Arthritis Evolving to Rheumatoid or Psoriatic Arthritis , 2021, Frontiers in Medicine.
[9] W. Tillett,et al. Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis , 2021, Rheumatology.
[10] A. Ogdie,et al. Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study , 2021, Nature Reviews Rheumatology.
[11] A. Zabotti,et al. The transition from enthesis physiological responses in health to aberrant responses that underpin spondyloarthritis mechanisms , 2020, Current opinion in rheumatology.
[12] A. Zabotti,et al. From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention , 2020, Current Rheumatology Reports.
[13] G. Schett,et al. Structural entheseal lesions in patients with psoriasis are associated with an increased risk of progression to psoriatic arthritis. , 2020, Arthritis & Rheumatology.
[14] V. Chandran,et al. Declining levels of serum chemokine (C‐X‐C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker? * , 2020, The British journal of dermatology.
[15] A. Iagnocco,et al. Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia , 2019, RMD Open.
[16] D. Gladman,et al. OP0203 CHARACTERIZING THE EPIGENOMIC LANDSCAPE OF PSORIASIS PATIENTS DESTINED TO DEVELOP PSORIATIC ARTHRITIS , 2019, Oral Presentations.
[17] J. Rasker,et al. Subclinical synovitis and enthesitis in psoriasis patients and controls by ultrasonography in Saudi Arabia; incidence of psoriatic arthritis during two years , 2019, Clinical Rheumatology.
[18] A. Ogdie,et al. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition , 2019, Nature Reviews Rheumatology.
[19] A. Gottlieb,et al. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta‐analysis of observational and clinical studies , 2019, Journal of the American Academy of Dermatology.
[20] M. Napolitano,et al. Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy. , 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.
[21] G. Shaddick,et al. Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis , 2018, The British journal of dermatology.
[22] P. Hannonen,et al. Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study. , 2018, Clinical and experimental rheumatology.
[23] L. Pérez,et al. AB1147 Evolutionary study of 45 cases of undifferentiated negative hla b27 seronegative oligoarthritis , 2018 .
[24] D. Gladman,et al. The Development of Psoriatic Arthritis in Patients With Psoriasis Is Preceded by a Period of Nonspecific Musculoskeletal Symptoms: A Prospective Cohort Study , 2016, Arthritis & rheumatology.
[25] D. Gladman,et al. The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study , 2016, Arthritis & rheumatology.
[26] A. Cavallaro,et al. Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis , 2016, Annals of the rheumatic diseases.
[27] P. Tak,et al. Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials , 2012, Annals of the rheumatic diseases.
[28] A. Ogdie,et al. Obesity and the risk of psoriatic arthritis: a population-based study , 2012, Annals of the rheumatic diseases.
[29] D. Moher,et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.
[30] S. Gabriel,et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. , 2009, Arthritis and rheumatism.
[31] I. Olivieri,et al. Sensitivity of the Classification of Psoriatic Arthritis Criteria in Early Psoriatic Arthritis , 2009, The Journal of Rheumatology.
[32] S. Lynch,et al. Recurrence risk for psoriasis and psoriatic arthritis within sibships. , 2005, Rheumatology.
[33] D. Gladman,et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome , 2005, Annals of the rheumatic diseases.
[34] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .